Status: February 2019 (preliminary)

Please click here for the detailed programme (preliminary, Feb 2019)


Programme at a glance

Sunday, 8 September 2019
08h00–21h00 Congress registration 16h00–21h00 Exhibition
10h30–16h00 Continuing Education Courses (CEC), including welcome coffee & lunch and afternoon coffee break
Development and evaluation of AOPs
Application and integration of increasingly mechanistically driven tools for risk assessment              
The pre-specified protocol part of evidence-based assessment in toxicology
Real world safety assessments for data-poor products: How to approach data gaps
Dietary exposure assessment
Determining safe exposure limits in occupational toxicology, application to pharmaceuticals
10h30–16h00 Satellite Meeting by ECETOC
Hazard Identification, Classification and Risk Assessment of Carcinogens: Too Much or Too Little?
(Free of charge but a separate registration is required, please click here to register.)
16h00 Opening of the Exhibition

Opening Ceremony including Keynote Lecture 1 and EUROTOX Merit Award


Welcome Reception in the Exhibition Area

Monday, 9 September 2019
08h00–18h00 Congress registration 09h00–16h30 Exhibition
09h00–10h00 Keynote Lecture 2
10h00–10h30 Coffee Break, Exhibition & Poster Viewing 1
10h30–12h30 Session 1
Metabolic capacity and functionality of the gut microbiome
Session 2
Fetus – the most sensitive individual
Session 3
The Exposome – understanding the role of environmental exposure in human health and disease
Session 4
How innate immune cells recognize toxicants
Session 5
New tools and application in reg. risk assessment – moving toward mechanistic risk assessment
12h30–13h30 Lunch Break, Exhibition & Poster Viewing 1


14h30–15h00 Coffee Break, Exhibition & Poster Viewing 1
15h00–17h00 Session 6
Developments in the use of systematic review in chemical risk assessment
Session 7
Speeding up hazard assessment of nanomaterials
Session 8
Human adaptation to environmental pollution: dose-response relationship revisited
Session 9
Application of new approach methods and development of integrated approaches to testing and assessment – moving toward mechanistic risk assessment
Session 10
The process of ageing and its modulation: telomeres as biomarkers in in vitro and in vivo studies

Specialty Section Meetings


19h30–21h30 City Hall Reception, sponsored by the City of Helsinki  
Tuesday, 10 September 2019
08h00–18h00 Congress Registration 09h00–16h30 Exhibition  

SOT Merit Award Lecture

10h00–10h30 Coffee Break, Exhibition & Poster Viewing 2
10h30–12h30 Session 11
Challenges of non-animal approaches for food safety: from inception to application
Session 12
Implications of biodistribution of inhaled nanoparticles: effects in organs other than the lung
Session 13
Knowledge-based computational approaches in predictive toxicology
Session 14
Understanding the interindividual variability in toxicity involving the psychotropic drugs
Session 15
Investigative Toxicology Leaders Forum (ITLF):
Scientific advancements and case studies for the optimization of drug discovery. Trends in investigative toxicology
12h30–13h30 Lunch Break, Exhibition & Poster Viewing 2
13h30–14h30 ILSI/HESI Lecture
14h30–15h00 Coffee Break, Exhibition & Poster Viewing 2
15h00–17h00 Session 16
Chemical risk assessment using human in vitro, ex vivo, in silico and biomonitoring data
Session 17
Experimental comprehensive toxicological studies simulating real-life exposures: Long-term combined exposures on multi endpoints
Session 18
Biomarkers in predictive toxicology and risk assessment
Session 19
Endocrine Disruption-Identification of root causes
Session 20
Investigative Toxicology Leaders Forum (ITLF): Scientific advancements and case studies for the optimization of drug discovery. DILI case studies
20h00–0h00 Congress Dinner at Clarion Hotel
Wednesday, 11 September 2019
08h00–13h00 Congress Registration 09h00–12h00 Exhibition

Bo Holmstedt Memorial Fund Lecture

09h30–11h30 Session 21
Comprehensive toxicological profiles in nanoformulations for blood brain barrier
Session 22
Advancing toxicological evaluations in resolving current policy controversies in GMO products
Session 23
Optimization of existing and construction of new testing strategies for skin sensitization potency
Session 24
Toxic epidemics: why should we still be worried in 2019?
Session 29
Species specific gastrointestinal (GI) toxicity in rabbits – what does it mean for prenatal developmental toxicity (PNDT) studies and their regulatory use?
11h30–12h00 Coffee Break & Exhibition
12h00–14h00 Session 25
Detection, assessment, management and communication of risk in mass human toxic exposures
Session 26
Suitability of non-animal approaches in different industries: One size fits all?
Session 27
Neurotoxicity in the scientific and regulatory outlook
Session 28
Hepatotoxicity: mechanisms, new insight into liver function, and possibilities of in vitro prediction
Session 30
Substances of Unknown or Variable composition, Complex reaction products or Biological materials (UVCBs); new challenges in their toxicological evaluation and risk management in REACH
14h00–14h30 Closing Ceremony and Awards presentation